Hatchtech's Series B Round

Hatchtech raised a round of funding on October 31, 2013.

Hatchtech is the developer of a proprietary next generation head lice treatment, DeOvo™. DeOvo™, recently renamed as Xeglyze™ Lotion, is a head lice product in development that has been studied …

Articles about Hatchtech's Series B Round: